Genetic variants of narcolepsy are tied to sleep characteristics including sleep efficiency, wake up time, and difficulty sleeping through the night.

Erenumab significantly improved quality of life and disability among patients with chronic and episodic migraine over a 2-year period.

Compared with the general population and those hospitalized for other infections, older adults with severe herpes zoster have a higher risk for dementia.

Intracranial GCA appears to be more common than previously thought and is linked to higher rates of stroke and mortality.

A substantial number of US dementia cases could be eliminated by mitigating modifiable cardiometabolic risk factors.

For patients undergoing noncardiac surgery, neurocognitive outcomes do not differ with hypotension-avoidance and hypertension-avoidance strategies.

Both CPAP and tirzepatide are acceptable treatments for comorbid obesity and OSA, with providers favoring CPAP and patients preferring tirzepatide.

Approximately one-third of pediatric mental health emergency department visits resulting in admission or transfer exceeded 12 hours.

There are few sex differences in narcolepsy type 1 symptom onset, but women have longer sleep times, higher efficiency, and men have higher BMI.

The Sleep Train Program improves sleep and behavior in children with both externalizing issues and sleep problems, but not in those with behavior issues alone.

Chronic migraine with or without aura was significantly associated with an increased risk for PPD, particularly in women with psychiatric and obstetric comorbidities.

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.